logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/11/2025
Hon Hai: It is expected that the revenue of artificial intelligence servers in the fourth quarter will increase compared to the previous quarter.
Latest
1 m ago
Hong Kong Stock Market Movement | AIDC Precision (01286.HK) rises nearly 7%, stock price hits new high on listing, boosting demand for powerful engines
2 m ago
Every AI express, Chengtong Securities released a research report on November 11, giving Tsingtao Brewery (600600.SH) a "strongly recommended" rating. The reasons for the rating mainly include: 1) the company's revenue growth rate in the first three quarters of 2025 was 1.41%, and the leading enterprise performed steadily under industry pressure; 2) the gross profit margin increased to 43.7%, and the net profit margin increased to 18.4%; 3) Tsingtao Brewery's sales volume steadily increased in the first three quarters, with outstanding performance of high-end products; 4) the company's brand value and high industry position, increasing dividends continuously enhance the attractiveness of the company; 5) the acquisition of Jimo Yellow Wine was stopped due to the influence of the target company. (Daily Economic News)
3 m ago
Every Economic AI News, Huayuan Securities released a research report on November 12th, giving "buy" rating to Audiway (920491.SH). The reasons for the rating mainly include: 1) Continuous benefits from the upgrade of intelligent assisted driving system, and the potential to strengthen overseas layout through H-share financing; 2) Diversified layout in non-automotive fields, supporting the commercialization of AI server cooling, service robots and other scenarios. (Daily Economic News)
3 m ago
According to the AI flash news of Every Business, Open Source Securities released a research report on November 12th, giving a "buy" rating to Huadong Medicine (000963.SZ). The rating reasons mainly include: 1) Multiple MNCs are rushing to target FGF21, and the company's layout of MASH indications is building differentiated barriers; 2) "Pharma valuation reshaping" represents the company, and innovative transformation is accelerating. 3) The phase 2 results of DR10624 were announced at AHA2025, and the results of SHTG were outstanding. (Daily Economic News)
3 m ago
Wan Xuejun has been appointed as the Secretary of the Party Committee of the China Youth Entrepreneurship and Employment Foundation.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.